Diagnosis of fusion genes using targeted RNA sequencing
Heyer, E.E., Deveson, I.W., Wooi, D. et al. Diagnosis of fusion genes using targeted RNA sequencing. Nat Commun 10, 1388 (2019). https://doi.org/10.1038/s41467-019-09374-9
Abstract
Fusion genes are a major cause of cancer. Their rapid and accurate diagnosis can inform clinical action, but current molecular diagnostic assays are restricted in resolution and throughput. Here, we show that targeted RNA sequencing (RNAseq) can overcome these limitations. First, we establish that fusion gene detection with targeted RNAseq is both sensitive and quantitative by optimising laboratory and bioinformatic variables using spike-in standards and cell lines. Next, we analyse a clinical patient cohort and improve the overall fusion gene diagnostic rate from 63% with conventional approaches to 76% with targeted RNAseq while demonstrating high concordance for patient samples with previous diagnoses. Finally, we show that targeted RNAseq offers additional advantages by simultaneously measuring gene expression levels and profiling the immune-receptor repertoire. We anticipate that targeted RNAseq will improve clinical fusion gene detection, and its increasing use will provide a deeper understanding of fusion gene biology.

Related Publications
RNA
Spliced synthetic genes as internal controls in RNA sequencing experiments
Nature Methods
Mar 27, 2019Read Abstract
General
Chiral DNA sequences as commutable controls for clinical genomics
Nature Communications
Mar 27, 2019Read Abstract
WGS
Use of synthetic DNA spike-in controls (sequins) for human genome sequencing
Nature Protocols
Mar 27, 2019Read Abstract